Live stream preview

Annovis Bio Enrolls Over 850 Patients for Its Next Alzheimer's Disease Trial

Annovis Bio's Sarah MacCallum and Cheng Fang joins Ashley Mastronardi on NYSE Live to discuss the next alzheimers disease trial